Skip to main content
Log in

Co-expression of bcl-2 and bag-1, apoptosis suppressing genes, prolonged viable culture period of hybridoma and enhanced antibody production

  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

Human bcl-2 and bag-1 DNA were introduced into mouse hybridoma 2E3- O cells and expressed. The expression of bcl-2 in BCMGneo-bcl2 transfectants was confirmed by ELISA and that of bag-1 in pZeo-bag1 was confirmed by western blotting. In batch cultures, the over-expression of bcl-2 prolonged the culture period by 2 days and co-expression of bcl-2 and bag-1 prolonged the culture period by 3 days. The delayed increase in the dead cell number in culture of the bcl-2 and bag-1 cotransfectant indicated the additional antiapoptosis effect of bcl-2 and bag-1 cotransfection in comparison with the bcl-2 only transfection. The bcl-2 transfectants (2E3O-Bcl2) produced antibody twofold per batch culture in comparison with 2E3-O cells transfected with BCMGSneo (2E3O-Mock). Enhancement of this MoAb production was due to the improved survival of the cells and was not due to stimulation of antibody production rate per cell by Bcl-2 expression. And the bcl-2 and bag-1 co-transfectant (2E3O-Bcl2-BAG1) produced antibody approximately fourfold of 2E3O-Mock per batch culture. Enhancement of this MoAb production was due to the improved survival of the cells and was partly due to stimulation of MoAb production rate per cell in the non-growing phase by the cotransfection. The method to engineer hybridoma cells genetically with bcl-2 and bag-1 for increasing viability and productivity would be widely applied for improving antibody productivity of hybridoma cultures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Duke RC and Cohen JJ (1992) Morphological and biochemical assays of apoptosis, In: K Janssen (ed) Current protocols in immunology (pp. 3.17.1–3.17.16). Wiley, New York.

    Google Scholar 

  • Duval D, Demangel C, Geahel I, Blondeau K and Marcaded A (1990) Comparison of various methods for monitoring hybridoma cell proliferation. J Immunol Meth 134: 177–185.

    Article  CAS  Google Scholar 

  • Itoh Y, Ueda H, Tsujimoto Y and Suzuki E (1995) Overexpression of bcl-2, apoptosis suppressing gene: prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng 48: 118–122.

    Article  CAS  Google Scholar 

  • Makishima F, Terada S, Mikami T and Suzuki E (1992) Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivuty. Cytotechnology 10: 15–23.

    Article  CAS  Google Scholar 

  • Pettersson M, Jernberg-Wiklund H, Larsson, LG, Sundstrom C, Givol I, Tsujimoto Y and Nilsson K (1992) Expression of the bcl-2 gene in human miltiple myeloma cell lines and normal plasma cells. Blood 79: 495–502.

    CAS  Google Scholar 

  • Perreault J and Lemieux R (1994) Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas. Cytotechnology 13: 99–105.

    Article  Google Scholar 

  • Simpson NH, Milner AE and Al-Rubeai M (1997) Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol Bioeng 54: 1–16.

    Article  CAS  Google Scholar 

  • Singh RP, Emery AN and Al-Rubeai M. (1996) Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene bcl-2. Biotechnol Bioeng 52: 166–175

    Article  CAS  Google Scholar 

  • Suzuki E and Ollis DF (1990) Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structure model. Biotechnol Prog 6: 231–236.

    Article  CAS  Google Scholar 

  • Takahashi K, Terada S, Ueda H, Makishima F and Suzuki E (1994) Growth rate suppression of cultured mammalian cells enhances protein productivity. Cytotechnology 15: 54–64.

    Article  Google Scholar 

  • Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA and Reed JC (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 80: 279–284.

    Article  CAS  Google Scholar 

  • Terada S, Itoh Y, Ueda H and Suzuki E (1997) Characterization and Fed-batch Culture of Hybridoma Overexpressing Apoptosis Suppressing Gene bcl-2. Cytotechnology 24: 135–141.

    Article  CAS  Google Scholar 

  • Terada S, Fukuoka K, Fujita T, Komatsu T, Takayama S, Reed JC and Suzuki E (1997) Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology 25: 17–23.

    Article  CAS  Google Scholar 

  • Terada S, Itoh Y and Suzuki E (1998) Establishing an apoptosis-resistant hybridoma cell line for usage in serum starvation culture. Kagaku Kogaku Ronbunshu 24: 161–164.

    CAS  Google Scholar 

  • Tomei LD (1991) Apoptosis: a program for death or survival? In: LD Tomei and FO Cope (eds) Apoptosis: the molecular basis of cell death (pp. 279–316). Cold Spring Harbor Laboratory Press, Cold Spring, NY.

    Google Scholar 

  • Tsujimoto Y (1989) Stress-resistance conferred by high level of bcl-2a protein in human B lymphoblastoid cell. Oncogene 4: 1331–1336.

    CAS  Google Scholar 

  • Vomastek T and Franek F (1993) Kinetics of development of spontaneous apoptosis in B cell hybridoma cultures. Immunol Lett 35: 19–24.

    Article  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terada, S., Komatsu, T., Fujita, T. et al. Co-expression of bcl-2 and bag-1, apoptosis suppressing genes, prolonged viable culture period of hybridoma and enhanced antibody production. Cytotechnology 31, 143–151 (1999). https://doi.org/10.1023/A:1008080407581

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008080407581

Navigation